Copper-deficient Rats have Altered Plasma Dihydroxyphenylacetic acid and Spleen Catecholamine Levels

Area of Science:

• Neuroscience
• Nutritional Biochemistry
• Developmental Biology

Background:

• Perinatal copper deficiency is a concern with potential impacts on development.
• Copper is essential for various enzymatic activities, including those involved in neurotransmitter synthesis.

Purpose of the Study:

• To investigate the effects of perinatal copper deficiency on growth and catecholamine levels in Sprague Dawley rats.
• To explore the relationship between copper status and dopamine (DA) and norepinephrine (NE) metabolism.
• To assess the utility of plasma dihydroxyphenylacetic acid (DOPAC) as a biomarker for copper status.

Main Methods:

• Induction of copper deficiency in pregnant and lactating Sprague Dawley rats and their offspring.
• Dietary copper manipulation in adult male Holtzman rats.
• Measurement of body weight, organ weights, and tissue copper levels.
• Quantification of plasma and spleen catecholamines (DA, NE) and their metabolites (DOPAC, DHPG) using High-Performance Liquid Chromatography (HPLC).

Main Results:

• Copper-deficient rats exhibited reduced body weight and increased heart/body weight ratio compared to controls.
• Elevated plasma DOPAC levels were observed in both male and female copper-deficient rats.
• Spleen norepinephrine levels were decreased in deficient males, while spleen dopamine levels were increased in both genders.
• Postnatal copper deficiency in adult rats showed similar trends in plasma DOPAC, spleen NE, and spleen DA.

Conclusions:

• Perinatal copper deficiency significantly affects growth and alters catecholamine metabolism, particularly dopamine pathways.
• The observed changes suggest potential limitations in dopamine-β-monooxygenase (DBM) activity.
• Plasma DOPAC levels show promise as a sensitive indicator of nutritional copper status.